“In the case of certain medicines, namely breast
cancer drugs for example, there were such strong pressures
from patients that they (the English) ended up adopting the
drug despite the fact that its cost effectiveness ratio was above
the 30 K/QALY threshold simply because there was nothing else
available out there”